Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.7T | 22.8T | 22.2T | 21.7T |
Cost of revenue | 17.1T | 17.8T | 16.8T | 16.0T |
Gross profit | 5.6T | 5.0T | 5.4T | 5.7T |
Operating expense | ||||
Research & development | — | 695.8B | 683.1B | 677.9B |
Selling general and admin | 4.3T | 4.1T | 3.9T | 3.8T |
Other operating expenses | — | — | — | — |
Operating income | 5.6T | 135.3B | 751.9B | 1.2T |
Non operating interest income | ||||
Income | — | 116.4B | 123.7B | 123.3B |
Expense | — | 144.0B | 142.4B | 161.8B |
Other income expense | — | — | — | — |
Pretax income | 1.1T | -1.1T | 534.9B | 896.7B |
Tax provision | 241.0B | -391.1B | 188.1B | 267.2B |
Net income | 875.6B | -713.8B | 90.2B | 629.5B |
Basic EPS | 2.2K | — | 134 | 1.6K |
Diluted EPS | 2.2K | — | 134 | 1.6K |
Basic average shares | — | — | 362.5M | 360.2M |
Diluted average shares | — | — | 362.5M | 360.2M |
EBITDA | 5.6T | 333.8B | 1.6T | 1.9T |
Net income from continuing op. | — | -713.8B | 90.2B | 629.5B |
Minority interests | -76.6B | -1.1B | -41.7B | -70.4B |
Preferred stock dividends | — | — | — | — |